ロード中...
In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles
Gemcitabine (Gemzar®) is the first line treatment for pancreatic cancer and often used in combination therapy for non-small cell lung, ovarian, and metastatic breast cancers. Although extremely toxic to a variety of tumor cells in culture, the clinical outcome of gemcitabine treatment still needs im...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3079786/ https://ncbi.nlm.nih.gov/pubmed/21371545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2011.02.037 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|